Nurse Practitioner, Family · Tyler, TX
NPI
1588289532
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
910 E Houston St Ste 550
Tyler, TX, 75702
Phone (903) 606-8718
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
705 services
Medicare patients, 2024
323
Average age 74
Drug cost, 2024
$806K
1,488 prescriptions
Company payments, 2025
$1,257
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julieta B Almazan was code 99213 (office e&m - established), 356 times for 228 patients. In total Julieta B Almazan billed 705 services in 16 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 356 | 228 | $39.01 | $14K |
| 99214 Office E&M - Established | Facility | 153 | 133 | $57.02 | $8,723 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 112 | 94 | $10.30 | $1,153 |
| 99443 Telephone Services | Facility | 38 | 31 | $58.73 | $2,232 |
| 36415 Venipuncture Blood Collection | Office | 19 | 12 | $8.16 | $155 |
By year: 2022 $11K for 217 services; 2023 $24K for 568 services; 2024 $27K for 705 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 12 | $8.16 | $155 |
Medicare prescription drug claims, 2024
In 2024, the drug Julieta B Almazan prescribed most often to Medicare patients was Pantoprazole Sodium, with 336 prescriptions and refills. In total Julieta B Almazan wrote 1,488 Medicare prescriptions that cost $806K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 336 | 703 | 124 | $3,485 |
| Famotidine Generic | 202 | 397 | 71 | $3,970 |
| Omeprazole Generic | 198 | 419 | 68 | $2,808 |
| Colestipol Hcl Generic | 184 | 300 | 58 | $16K |
| Esomeprazole Magnesium Generic | 95 | 171 | 25 | $2,197 |
| Dicyclomine Hcl Generic | 86 | 103 | 43 | $1,808 |
| Linzess Linaclotide | 53 | 73 | 15 | $38K |
| Sucraid Sacrosidase | 35 | 41 | Under 11 | $517K |
| Ondansetron Odt Ondansetron | 31 | 31 | 20 | $376 |
| Sucralfate Generic | 20 | 22 | Under 11 | $1,497 |
| Amitriptyline Hcl Generic | 19 | 21 | Under 11 | $184 |
| Creon Lipase/Protease/Amylase | 19 | 31 | Under 11 | $61K |
| Xifaxan Rifaximin | 19 | 19 | 16 | $39K |
| Neomycin Sulfate Generic | 16 | 16 | 14 | $500 |
| Furosemide Generic | 14 | 16 | Under 11 | $36.05 |
Brand drugs: 210 claims; generic drugs: 1,278 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julieta B Almazan $1,257 ($1,257 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $406.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $406 |
| Janssen Biotech, Inc. JNJ | 2 | $205 |
| Genzyme Corporation SNY | 6 | $201 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $119 |
| Ardelyx, Inc. ARDX | 1 | $106 |
| Novo Nordisk Inc NVO | 1 | $46.3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $20.41 |
| Mirum Pharmaceuticals, Inc. MIRM | 1 | $14.19 |
| QOL Medical, LLC | 1 | $14.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.